Cost-Effectiveness

Screening Children and Young Adults for Familial Hypercholesterolemia: Clinically Helpful but Not Cost‑Effective

By MedXY 11/10/2025

A modeling study found that sequential population screening for familial hypercholesterolemia (FH) at ages 10 or 18 is clinically effective but not cost‑effective versus usual care, unless follow-up monitoring and lifestyle interventions for non‑FH dyslipidemia increase substantially.

Cardiology Emergency Medicine Family Medicine & Nutrition news

Evaluating the Impact and Economics of Home Automated External Defibrillators: Insights from the CARES Registry

By MedXY 10/29/2025

AEDs improve survival in in-home cardiac arrests with shockable rhythms but are not cost-effective for widespread private home use at current prices and incidence rates, per a large US cohort study using CARES data.

Critical Care news Rehabilitation Medicine Respiratory

Evaluating the Cost-Effectiveness of Early In-Bed Cycling Plus Routine Physiotherapy in Mechanically Ventilated ICU Patients: Insights from the CYCLE Trial

By MedXY 10/27/2025

This economic evaluation from the CYCLE randomized trial found no significant cost or quality-adjusted life-year benefit by adding early in-bed cycling to usual physiotherapy for ICU patients on mechanical ventilation, underscoring a need for further research to clarify its value.

Clinical Updates OB/GYN & Women's Health Public Health Specialties

Cost-Effectiveness of Mailed HPV Self-Testing Kits for Cervical Cancer Screening Across Diverse Screening Histories

By MedXY 10/01/2025

Economic evaluation shows direct mailing of HPV self-sampling kits improves cervical cancer screening completion and is cost-effective among varied screening history groups in a US healthcare system, with budget benefits over time.

OB/GYN & Women's Health Oncology Specialties

Evolving Trends and Economic Implications of Breast Cancer Screening in Older US Women: Navigating Value and Cost

By MedXY 09/28/2025

Breast cancer screening among older US women shows stable use but rising costs driven by low-value technologies; optimizing screening strategies could enhance value and reduce expenditure.

Cardiology news Specialties

Novel Contrast-Derived Indices of Coronary Microvascular Function: Potential Clinical and Cost Benefits

By MedXY 08/13/2025

This study evaluates new contrast-derived indices of coronary microvascular function, highlighting their diagnostic potential and cost-effectiveness compared to traditional adenosine testing.